Skip to main content
Back to Mitsubishi UFJ Capital

Mitsubishi UFJ Capital's Biotechnology Portfolio

Browse 22 Biotechnology companies funded by Mitsubishi UFJ Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
22
Total Funding in Biotechnology
$266.4M

Biotechnology Portfolio Companies (22)

Export
Animal FeedAquacultureBiotechnologyConsumer ResearchOrganicRecyclingSustainability

Symbiobe is a research and development agency that effectively utilizes untapped natural biomass resources and photosynthetic organisms.

Kyoto, Japan
September 2024
$5.7M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife Science

Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.

Ishikawa, Japan
August 2025
$13.6M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareMedical

Logomix is a biotechnology company that specializes in medication research, cell therapy, and clinical trials.

Harumi, Japan
July 2025
$18.8M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Diagnostics

RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.

Tokyo, Japan
July 2021
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Tokyo, Japan
June 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Tokyo, Japan
June 2026
$32.8M
Series B

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiopharmaBiotechnologyMedicalPharmaceutical

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

Hiroshima, Japan
June 2025
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareLife Science

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

Kyoto, Japan
May 2024
$6.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyEnvironmental ConsultingManagement ConsultingMedicalNursing and Residential CareWeb Development

Epsilon Molecular Engineering is a biotechnology company focuses on biomolecule and aptamer development for therapeutic applications.

Saitama, Japan
May 2026
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct ResearchSensor

Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.

Nara, Japan
April 2026
$1.9M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical DeviceWellness

Sonia Therapeutics is a medical equipment manufacturing company that develops a device for ultrasound treatment system.

Shinjuku, Japan
April 2026
$13.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalProduct Design

StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.

Kumamoto, Japan
April 2024
$3.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical

FELIQS is a research-based start-up specializing in pharmaceutical sciences.

Kurume, Japan
July 2025
$8.3M
Series A

Founder Contacts

30,000+ verified contacts

B2BBiotechnologyGeneticsHealth Care

Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.

Fujisawa, Japan
June 2025
$5.3M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Kyoto, Japan
December 2024
$955K
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingMedicalRental

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

Kyoto, Japan
October 2024
$15.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

South San Francisco, United States
August 2024
$68.0M
Series A

Founder Contacts

30,000+ verified contacts

AgricultureBiotechnologyEnvironmental ConsultingLife Science

GRA&GREEN is a biotechnology company that provides seed development for agriculture, forestry, and raw materials for food processing.

Nagoya, Japan
June 2024
$4.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPrecision MedicineProduct ResearchTherapeutics

Luxana Biotech is a biotechnology firm aimed at developing nucleic acid drugs to enhance medical treatment for patients in need.

Osaka, Japan
August 2025
$1.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalNursing and Residential CarePharmaceutical

Alchemedicine is a biotechnology company that conducts internal and joint drug research and discovery programs.

Tsukuba, Japan
February 2021
$7.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareWellness

CellAxia is a biotechnology firm that researches, develops, and markets pharmaceuticals and regenerative medicine products.

Tokyo, Japan
September 2020
$6.6M
Series B

Founder Contacts

30,000+ verified contacts

Explore Mitsubishi UFJ Capital's Full Portfolio

View all companies funded by Mitsubishi UFJ Capital across every industry and funding stage.

View Full Mitsubishi UFJ Capital Portfolio